| Literature DB >> 22848211 |
Abstract
St. John's Wort herb extracts often contain undesirable or volitional polysaccharides. As polysaccharides exhibit structure-dependent biological functions in the present study water-soluble polysaccharides were extracted from herb material, fractionated by anion exchange chromatography into four main polysaccharide fractions (denominated as Hp1, Hp2, Hp3 and Hp4) and characterized by HPAEC-PAD, CE, IR and GC-MS. Biological activity on human skin keratinocytes and fibroblasts was assessed by investigation of their effect on proliferation, metabolism, cytotoxicity, apoptosis and differentiation. The underlying mechanisms were investigated in gene expression studies. Polysaccharide fraction Hp1 was mainly composed of β-D-glucose. Hp2, Hp3 and Hp4 contained pectic structures and arabinogalactan proteins varying in composition and quantity. Polysaccharides of Hp1 induced the keratinocyte differentiation by inhibiting the gene expression of the epidermal growth factor and insulin receptor. While the collagen secretion of fibroblasts was stimulated by each polysaccharide fraction only Hp1 stimulated the synthesis. The fibroblast proliferation was reduced by Hp1 and increased by Hp4. This effect was related to the influence on genes that referred to oxidative stress, metabolism, transcription processes and extracellular proteins. In conclusion polysaccharides have been shown as biologically active ingredients of aqueous St. John's Wort extracts with a relation between their structural characteristics and function.Entities:
Year: 2012 PMID: 22848211 PMCID: PMC3405560 DOI: 10.1155/2012/304317
Source DB: PubMed Journal: Adv Pharmacol Sci ISSN: 1687-6334
TaqMan Assay IDs (Applied Biosystems, Foster City, USA) of specific proteins and representatives of signal pathways expressed in normal human fibroblasts (NHDFs) and normal human keratinocytes (NHEKs) investigated by real-time PCR after treatment with 10 μg/mL St. John's Wort herb polysaccharide fractions.
| Gene | Function | TaqMan Assay ID |
|---|---|---|
| Epidermal growth factor receptor (EGFR) | Proliferation | Hs01076068m1 |
| Fibroblast growth factor 7 (FGF7) | Proliferation | Hs00384281_m1 |
| Insulin receptor (InsR) | Survival/proliferation | Hs00169631m1 |
| Involucrin (Inv) | Differentiation-specific protein | Hs00846307s1 |
| Signal transducer and activator of transcription 6 (STAT6) | IL-4 signal transduction | Hs00598618_m1 |
| Phospholipase | Ca2+ signaling | Hs00179898_m1 |
| Human 18s rRNA (18s) | Endogenous control | Hs99999901s1 |
Results of methylation analysis and AGP determination of St. John's Wort polysaccharides. Data indicate the respective molar composition [%], calculated from results of HPAEC-PAD and silylation analysis. AGP amounts were detected by the agar diffusion test according to van Holst and Clarke, 1985 [20].
| Hp1 | Hp2 | Hp3 | Hp4 | |
|---|---|---|---|---|
| 1-Ara | 6 | 23 | 6 | 1 |
| 1,2-Ara | 1 | 1 | ||
| 1,3-Ara | 3 | 2 | ||
| 1,5-Ara | 6 | 5 | 12 | 10 |
| 1,3,5-Ara | 2 | 3 | 1 | 2 |
| 1,2,3-Ara | 2 | 3 | ||
| 1,2,5-Ara | 2 | 1 | 7 | |
| 1,3,4,5-Ara | 1 | |||
| Arapent | 1 | |||
|
| ||||
| 1-Rha | 1 | 3 | 4 | |
| 1,2 Rha | 1 | 2 | 2 | |
| 3,4/1,4-Rha | 9 | 2 | ||
| 1,2,3-Rha | 1 | 2 | 6 | |
|
| ||||
| 1-Xyl | 1 | |||
| 1,2-Xyl | 1 | 1 | 1 | |
| 1,3,5-Xyl | 1 | |||
|
| ||||
| 1-Man | 1 | |||
| 1,4-Man | 2 | 2 | 3 | 3 |
| 1,4,6-Man | 1 | 1 | ||
|
| ||||
| 1-Glc | 7 | 1 | ||
| 1,3-Glc | 5 | 2 | ||
| 1,4-Glc | 11 | 1 | 1 | 3 |
| 1,6-Glc | 26 | 2 | 1 | |
| 1,2,4-Glc | 2 | |||
| 1,4,6-Glc | 3 | 1 | ||
|
| ||||
| 1-Gal | 1 | 1 | 1 | |
| 1,3-Gal | 2 | 1 | 3 | 3 |
| 1,6-Gal | 5 | 5 | 5 | 3 |
| 3,6-Gal | 1 | 1 | 1 | |
| 1,2,4-Gal | 1 | 1 | ||
| 1,4,6-Gal | 3 | 2 | 1 | |
| 1,3,6-Gal | 6 | 23 | 21 | 5 |
| 1,3,4,6-Gal | 1 | 2 | 1 | |
|
| ||||
| 1,4-GlcAc | 3 | 18 | 8 | 6 |
|
| ||||
| 1,3-GalAc | 17 | |||
| 3,6-GalAc | 15 | |||
| 1,3,6-GalAc | 2 | |||
| 1,2,4-GalAc | 13 | |||
|
| ||||
| AGP amount [%] | 0 | 75 | 3 | 3 |
Influence of St. John's Wort polysaccharides on cell physiology of keratinocytes (NEHK and HaCaT). Results were normalized to the untreated cells calculated as 0%. Proliferation was determined by BrdU incorporation ELISA. MTT reduction assay was performed to investigate the intracellular enzyme activity. The cytotoxicity was determined by calculating the extracellular LDH activity compared to total LDH activity according to the manufacturer instructions. Apoptosis was measured by flow cytometry using Annexin V and 7-AAD.
| Polysaccharide fraction | Proliferation rate (NHEK) | Intracellular enzyme activity (NHEK) | Amount of necrotic cells (NHEK) | Amount of apoptotic cells (HaCaT) |
|---|---|---|---|---|
| Hp1 | 16% ± 8 | 17% ± 7 | 0% | 13% ± 11 |
| Hp2 | 16% ± 9 | 23% ± 7 | 4% | 15% ± 10 |
| Hp3 | −17% ± 8 | 21% ± 10 | 8% | 21% ± 9 |
| Hp4 | 10% ± 7 | 13% ± 6 | 5% | 6% ± 3 |
Figure 1Expression of differentiation-specific protein involucrin of NHEK after treatment with 10 μg/mL St. John's Wort polysaccharide fractions for nine days. Protein amounts were determined by semiquantitative dot blot technique. Obtained values with n = 8 were normalized to untreated NHEK (—: untreated NHEK = 100%). To induce the differentiation, the serum-starved MCDB 153 complete media were supplemented with 13 μg/mL A23187 and 2 mM Ca2+ (positive control).
Gene expression of NHEK after 6 h of incubation with 10 μg/mL St. John's Wort polysaccharides in serum-starved media. Results of RT-PCR with TaqMan Assays were normalized to endogenous control 18srRNA and to respective target gene expression of untreated control cells. Regulation was defined as significant with >2 (+) and <0.5 (−). No change in gene expression is shown as “o”.
| Involucrin | PLA2 | EGFR | InsR | |
|---|---|---|---|---|
| Hp1 | o | − | − | − |
| Hp2 | o | o | o | o |
| Hp3 | o | o | o | o |
| Hp4 | o | + | o | o |
Figure 2Results of relative proliferation (BrdU incorporation, representative with n = 8) and intracellular (MTT-reduction) and extracellular enzyme activity (WST-1 reduction) of NHDF treated with 10 μg/mL St. John's Wort polysaccharides for 48 h. As positive control, 10% FCS was used. Values were normalized to untreated cells (—: untreated control = 100%). n = 24. Error bars = SE; *P < 0.05 compared to untreated cells and o: P < 0.05 to Hp4.
Figure 3Relative amounts of acid soluble collagen of fibroblast culture supernatants and fibroblasts after incubation with 100 mM L-ascorbic acid as positive control and polysaccharide fractions (10 μg/mL). Results were indirectly calculated by determination of hydroxyproline with Direct Red 80. Values shown are normalized to collagen amounts in supernatants and cells of untreated control (—: untreated control = 100%). *P < 0.05 compared to untreated cells; n = 4. Error bars = SE.
Gene expression of NHDF after incubation with 10 μg/mL St. John's Wort polysaccharide fractions in minimal MEM for 6 h, 12 h, and 24 h. Results of RT-PCR with TaqMan assays were normalized to endogenous control 18 srRNA and to the respected expression of target genes in untreated control cells. Regulation was defined as significant with >2 (+) and <0.5 (−). No change in gene expression is shown as “o”.
| Polysaccharide fraction | EGFR | STAT6 | FGF7 | Incubation time |
|---|---|---|---|---|
| Hp1 | − | − | − | 6 h |
| Hp2 | o | o | o | |
| Hp3 | o | o | o | |
| Hp4 | o | o | o | |
|
| ||||
| Hp1 | o | o | o | 12 h |
| Hp2 | + | o | o | |
| Hp3 | o | o | + | |
| Hp4 | o | o | + | |
|
| ||||
| Hp1 | − | o | − | 24 h |
| Hp2 | + | o | − | |
| Hp3 | o | o | − | |
| Hp4 | o | o | o | |
Summary of genes with significantly changed expression (>1.7, <0.5) from 1308 genes in total within gene expression analysis using topic-defined PIQOR skin microarray (Miltenyi Biotech, Cologne, Germany) from NHDF after treatment with polysaccharides of Hp4 (10 μg/mL) compared to an untreated control (=1) for 24 h.
| Gene | Description and function according to NCBI gene database | Relative regulation |
|---|---|---|
| (SD %) | ||
|
| ||
|
| ||
| LOC387763 | LOC387763 protein (unknown) | 2.70/9% |
| C9ORF16 | C9ORF16 (unknown) | 2.37/21% |
| ACTG2 | Gamma-2-actin (cell motility) | 2.01/29% |
| GJB6 | Connexin 30 (hyperproliferation) | 0.48/32% |
|
| ||
|
| ||
|
| ||
| HSPG2 | Perlecan | 3.05/33% |
| L1CAM | L1 cell adhesion molecule | 1.93/13% |
| FGF11 | Fibroblast growth factor 11 | 1.93/13% |
| PTK7 | Protein-tyrosine kinase 7 | 1.78/19% |
| FAT | Cadherin-related tumor suppressor | 1.73/13% |
| SPARCL1 | SPARC-like protein 1 | 0.48/22% |
| MMP7 | Matrilysin | 0.42/14% |
|
| ||
|
| ||
|
| ||
| NNMT | Nicotinamide N-methyltransferase | 2.83/17% |
| CA12_2 | Carbonic anhydrase XII | 1.98/11% |
| SLC20A1 | Member of solute carrier family 20 (phosphate transporter) | 1.89/10% |
| MDH1 | Cytoplasmic malate dehydrogenase | 1.84/21% |
|
| cAMP-dependent chloride channel | 1.80/4% |
|
| Solute carrier family 2 member 1 (facilitated glucose transporter) | 1.78/29% |
|
| Mesoderm-specific transcript homolog (mouse) | 1.71/17% |
|
| Cytochrome P450 3A7 | 0.47/23% |
|
| Afamin ( | 0.33/15% |
|
| ||
|
| ||
|
| ||
| NRP1 | Neuropilin-1 (CD304 Antigen) | 1.79/26% |
| INHBC | Inhibin | 0.46/19% |
| CD16 | IGG FC receptor III-2 | 0.43/21% |
| ZAP70 | Zeta-chain (TCR) associated protein kinase 70 kDa | 0.41/24% |
|
| ||
|
| ||
|
| ||
| EXOSC10 | Exosome component 10 | 2.96/37% |
| HOXD10 | Homeobox D10 | 2.04/20% |
| SRRM2 | Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa | 1.92/33% |
| MAZ | MYC-associated zinc finger protein (purine-binding transcription factor) | 1.91/17% |
| ANKRD11 | Ankyrin repeat domain 11 | 1.81/23% |
| MRPL28 | Mitochondrial ribosomal protein L28 | 1.74/15% |
| C-FOS | G0/G1 switch regulatory protein 7 | 0.21/1% |
|
| ||
|
| ||
|
| ||
| SOD2 | Mitochondrial superoxide dismutase 2 | 4.78/22% |
| CMTM7 | CKLF-like MARVEL transmembrane domain-containing protein 7 | 3.86/38% |
| CXCL1 | Chemokine (C-X-C motif) ligand 1 | 3.33/18% |
| IKBE | Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 3.18/38% |
| FEN1 | Flap structure-specific endonuclease 1 | 2.34/11% |
| BGLAP | Bone gamma-carboxyglutamate (gla) protein | 2.07/10% |
| MUTYH | A/G-specific adenine DNA glycosylase | 2.05/20% |
| BTF2P44 | Basic transcription factor 2 44 kDa subunit | 1.99/18% |
| IKBA | Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 1.89/5% |
| SERPIN 1 | Serine proteinase inhibitor | 1.83/6% |
| XBP1 | X-box binding protein 1 | 1.73/12% |
| HSP90B1 | Endoplasmin (heat shock protein 90 b1) | 1.73/21% |
| POLH | Polymerase eta (DNA directed) | 1.70/20% |
| IL17A | Interleukin 17 | 0.45/20% |
SD: standard deviations from n = 4 replicates of three biologic repeats.